MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-11532

  1. 2,479 Posts.
    lightbulb Created with Sketch. 274
    very distasteful.

    I get it, we all want to make a profit. but people are dying. and we should be happy that there are treatments that work.

    I believe MSB will probably get up the next time they go for the juvenile GVHD approval. they basically received a "revise and resubmit" which isn't THAT bad.

    but it's a little disturbing to see people still beating this Covid dead horse like it's their golden ticket.

    especially when there are people who accuse big pharma of doing the exact same thing.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.